{"transactions":[{"id":2058493,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T15:30:23.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":250000,"price":0.017,"value":4250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant shall be exercisable for a price of $0.017 per option share for ten years from January 5, 2023 and the options will vest in equal monthly installments over the one year period beginning November 10, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0.017,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-23-000008","document":"wf-form4_167327820816124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000008/wf-form4_167327820816124.xml","form_type":"4"}},{"id":2115869,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T17:24:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":195000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"8.33% of the options vested on the grant date of August 3, 2020. 8.33% of the options vest, or have vested, on each monthly anniversary of the grant date."}],"balance_after":195000,"derivative":{"exercise_price":0.08,"expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001516551-22-000045","document":"wf-form4_166853302798842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000045/wf-form4_166853302798842.xml","form_type":"4"}},{"id":2115868,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T17:24:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":146250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vest, or have vested, in equal installments on each of February 6, 2020, February 6, 2021, February 6, 2022, February 6, 2023."}],"balance_after":146250,"derivative":{"exercise_price":0.11,"expiration_date":"2025-02-06","underlying":"Common Stock","underlying_shares":146250},"source":{"system":"sec-edgar","filing":"0001516551-22-000045","document":"wf-form4_166853302798842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000045/wf-form4_166853302798842.xml","form_type":"4"}},{"id":2115867,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T17:24:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":146250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options underlying this award are fully vested."}],"balance_after":146250,"derivative":{"exercise_price":1.71,"expiration_date":"2022-12-22","underlying":"Common Stock","underlying_shares":146250},"source":{"system":"sec-edgar","filing":"0001516551-22-000045","document":"wf-form4_166853302798842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000045/wf-form4_166853302798842.xml","form_type":"4"}},{"id":2115866,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T17:24:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":390000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options underlying this award are fully vested."}],"balance_after":390000,"derivative":{"exercise_price":1.6,"expiration_date":"2024-04-02","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001516551-22-000045","document":"wf-form4_166853302798842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000045/wf-form4_166853302798842.xml","form_type":"4"}},{"id":2115865,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T17:24:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":73561,"ownership":{"direct":false,"nature":"Shares held by wife of Reporting Person"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"For each indirect account, Mr. Rai disclaims beneficial ownership except to the extent of his pecuniary interest, if any."}],"balance_after":73561,"source":{"system":"sec-edgar","filing":"0001516551-22-000045","document":"wf-form4_166853302798842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000045/wf-form4_166853302798842.xml","form_type":"4"}},{"id":2115864,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":120835,"kind":"person","name":"Rai Sukhwinder Singh","position":1,"cik":"0001947352","reported_name":"Rai Sukhwinder Singh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-15T17:24:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":22157,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held through the Canaccord Genuity Trust."}],"balance_after":22157,"source":{"system":"sec-edgar","filing":"0001516551-22-000045","document":"wf-form4_166853302798842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000045/wf-form4_166853302798842.xml","form_type":"4"}}]}